Fig 1.
Flowchart of inclusion and exclusion criteria for participant selection method.
Table 1.
Baseline characteristics according to statin type.
Table 2.
Cox-proportional hazard regression models for primary composite outcomes for each statin compared with simvastatin.
Table 3.
Cox-proportional hazard regression models for the recurrence of cardio-cerebrovascular events for each statin compared with simvastatin.
Fig 2.
Kaplan-Meier estimates of primary composite outcomes and cardio-cerebrovascular events.
A) Primary composite outcomes of all causes of death and/or recurrence of cardio-cerebrovascular disease (CCVD). B) Recurrence of cardio-cerebrovascular events.